PEPTIDE DERIVATIVE FOR REGULATING THYMIC STROMAL LYMPHOID PROTEIN-MEDIATED SIGNALING AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ALLERGY AND ASTHMA DISEASES COMPRISING SAME
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; SEJONG CAMPUS
发明人:
Youngjoo BYUN,Ki Yong LEE,Kiho LEE,Young Ho JEON,Yong Woo JUNG
申请号：
US15558286
公开号：
US20180148474A1
申请日:
2016.03.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a peptide derivative for regulating the thymic stromal lymphoid protein-mediated signaling and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases and, more particularly, to a peptide derivative represented by Chemical Formula 1 and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases. According to the present invention, provided are a peptide derivative capable of effectively inhibiting the formation of an inflammatory response of allergy and asthma diseases and a pharmaceutical composition including the peptide derivative. By using the present invention, various allergy and asthma diseases can be fundamentally prevented or treated.
